Small-cell lung cancer rapidly develops resistance to standard-of-care therapy. Two papers now establish xenograft models derived from patient-derived circulating tumor cells and show that initially homogeneous, chemoresponsive tumors rapidly recur as heterogeneous drug-refractory disease.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
A telomere-targeting drug depletes cancer initiating cells and promotes anti-tumor immunity in small cell lung cancer
Nature Communications Open Access 22 January 2024
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rudin, C. M. et al. Nat. Rev. Cancer 19, 289–297 (2019).
Stewart, C. A. et al. Nat. Cancer https://doi.org/10.1038/s43018-019-0020-z (2020).
Simpson, K. L. et al. Nat. Cancer https://doi.org/10.1038/s43018-020-0046-2 (2020).
Hodgkinson, C. L. et al. Nat. Med. 20, 897–903 (2014).
Lallo, A. et al. Clin. Cancer Res. 24, 5153–5164 (2018).
Drapkin, B. J. et al. Cancer Discov. 8, 600–615 (2018).
Gazdar, A. F. Oncogene 28, S24–S31 (2009).
George, J. et al. Nature 524, 47–53 (2015).
Mollaoglu, G. et al. Cancer Cell 31, 270–285 (2017).
Denny, S. K. et al. Cell 166, 328–342 (2016).
Calbo, J. et al. Cancer Cell 19, 244–256 (2011).
Lim, J. S. et al. Nature 545, 360–364 (2017).
McNair, C. et al. J. Clin. Invest. 128, 341–358 (2018).
Zocchi, L. et al. Oncogenesis 9, 25 (2020).
Ishak, C. A. et al. Mol. Cell 64, 1074–1087 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Berns, A. The therapy escapes of small-cell lung cancer. Nat Cancer 1, 374–375 (2020). https://doi.org/10.1038/s43018-020-0058-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s43018-020-0058-y